Pfizer

Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Endpoints
Pfizer
Xtandi
Talzenna
PARP inhibitors
Medivation
clinical trials
prostate cancer
Flag link:
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Pfizer
Voyager Therapeutics
capsids
gene therapy
Flag link:
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Fierce Pharma
Alnylam
Onpattro
Pfizer
ATTR-CM
Flag link:
Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing
Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing
Fierce Pharma
Pfizer
Albert Bourla
Pharma CEOs
COVID-19
Europe
vaccines
Flag link:
Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please
Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please
Endpoints
FDA
Pfizer
cancer
RTOR
oncology
Flag link:
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Yahoo/Reuters
Pfizer
BioNTech
COVID-19
FDA
vaccines
pediatric
boosters
Flag link:
Pfizer whittles down US donation deal as global COVID-19 vaccine demand slumps
Pfizer whittles down US donation deal as global COVID-19 vaccine demand slumps
Fierce Pharma
Pfizer
vaccines
COVID-19
Flag link:
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Fierce Biotech
Pfizer
clinical trials
hemophilia A
gene therapy
FDA
giroctocogene fitelparvovec
Flag link:
EASD 2022 – Pfizer’s oral GLP-1s struggle for a therapeutic window
EASD 2022 – Pfizer’s oral GLP-1s struggle for a therapeutic window
EP Vantage
Pfizer
EASD
danuglipron
diabetes
Flag link:
Pfizer to supply 6 million Paxlovid treatments to Global Fund
Pfizer to supply 6 million Paxlovid treatments to Global Fund
Axios
Pfizer
Paxlovid
COVID-19
Global Fund
Flag link:
Can This Tiny Biotech Take On Pfizer?
Can This Tiny Biotech Take On Pfizer?
Motley Fool
Prometheus Biosciences
Pfizer
inflammatory bowel disease
PRA023
Flag link:
BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts
BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts
Fierce Pharma
Pfizer
BioNTech
vaccines
COVID-19
Flag link:
Pfizer hit with racial discrimination lawsuit over minority fellowship program
Pfizer hit with racial discrimination lawsuit over minority fellowship program
Fierce Pharma
Pfizer
racial discrimination
legal
Flag link:
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV
Flag link:
Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel
Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel
Seeking Alpha
Pfizer
BioNTech
Moderna Therapeutics
EMA
CHMP
vaccines
COVID-19
Europe
Flag link:
Prometheus takes on Pfizer in inflammatory bowel diseases
Prometheus takes on Pfizer in inflammatory bowel diseases
EP Vantage
Prometheus Biosciences
Pfizer
PF-06480605
PRA023
inflammatory bowel disease
Flag link:
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Endpoints
Pfizer
vaccine
meningococcal disease
clinical trials
MenABCWY
Flag link:
Pfizer and Strata expand clinical partnership for cancer trial
Pfizer and Strata expand clinical partnership for cancer trial
Clinical Trials Arena
Pfizer
Strata Oncology
clinical trials
oncology
Flag link:
Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine
Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine
Fierce Biotech
Pfizer
Moderna Therapeutics
MRNA
vaccines
Flu
clinical tirals
Flag link:
Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape
Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape
Fierce Biotech
Oramed
NASH
diabetes
Pfizer
insulin
clinical trials
ORMD-0801
Flag link:

Pages